University of Tübingen-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2012

  1. MO19390 (SAiL): Bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC

    Lung Cancer, Vol. 76, Núm. 3, pp. 373-379